Canntab Therapeutics Limited, the leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, announced the impending launch of its suite of hard pill cannabinoid formulations in Australia with its partner CANN Global Ltd. CANN Global through its partnership with Medcan Australia Pty Ltd received an import permit and have placed an initial order for Canntab’s products. Canntab will immediately apply for an export permit with Health Canada, which will allow it to fulfill this purchase order. The Company intends to ship its suite of Patented and Patent Pending products, including THC, CBD, and THC/CBD combination hard pill formulations to CANN Global before the end of 2020.

Sean Hocking, Cannabis Law Report, 11/03/2020 04:46:11

Open article: